| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Elastin Biosciences, an emerging biotechnology company focused on developing small molecule therapies to address diseases and conditions linked to elastin deficiency, today announced its...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Abstracts offer insights into precision oncology diagnostics for triple-negative breast cancer, liquid biopsy and machine learning for tumor profiling BURLINGTON, N.C., May 30, 2024 /PRNewswire/...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced its...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
The 2024 edition of BIO International Convention 2024 (BIO), the world's largest and most comprehensive global biotech event, will be held from June 3 to 6 at San Diego Convention Center, San...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Ifebemtinib in combination with garsorasib in NSCLC showed ORR of 90.3% and DCR of 96.8% Ifebemtinib is a highly selective, orally administered, focal adhesion kinase inhibitor with significant...
